Atıf İçin Kopyala
Varrone A., Dickson J. C., Tossici-Bolt L., Sera T., Asenbaum S., Booij J., ...Daha Fazla
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.40, sa.2, ss.213-227, 2013 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
40
Sayı:
2
-
Basım Tarihi:
2013
-
Doi Numarası:
10.1007/s00259-012-2276-8
-
Dergi Adı:
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.213-227
-
Anahtar Kelimeler:
Dopamine transporter, Gender difference, Age effects, SPECT, Scatter correction, Database, PARKINSONS-DISEASE, DOPAMINE TRANSPORTERS, I-123-FP-CIT SPECT, BRAIN, PREVALENCE, NEUROTRANSMISSION, PROGRESSION, DIAGNOSIS, LEVODOPA, DECLINE
-
Gazi Üniversitesi Adresli:
Evet
Özet
Dopamine transporter (DAT) imaging with [I-123]FP-CIT (DaTSCAN) is an established diagnostic tool in parkinsonism and dementia. Although qualitative assessment criteria are available, DAT quantification is important for research and for completion of a diagnostic evaluation. One critical aspect of quantification is the availability of normative data, considering possible age and gender effects on DAT availability. The aim of the European Normal Control Database of DaTSCAN (ENC-DAT) study was to generate a large database of [I-123]FP-CIT SPECT scans in healthy controls.